Twitter shared news of first Ebola case 3 days before officials
Tweets regarding the Ebola outbreak in West Africa last summer reached more than 60 million people in the three days prior to official outbreak announcements, according to a study published in the American Journal of Infection Control.
Researchers from the Columbia University School of Nursing in New York analyzed over 42,000 Ebola-related tweets posted to the social networking site Twitter, from July 24 – August 1, 2014, the week in which Nigeria reported the first case of Ebola, Sierra Leone declared a national state of emergency and the first American was diagnosed with Ebola.
Twitter was a resource for those to share news of Ebola cases prior to official announcements from the Nigerian Ministry of Health, the World Health Organization and the Centers for Disease Control and Prevention. During the three days prior to an official announcement from the Nigerian Ministry of Health nearly 1,500 tweets were disseminated regarding Ebola.
“Twitter adoption in African countries like Nigeria has been exponentially increasing and it’s clear that Twitter is a useful resource for spreading breaking health news in these West African countries,” said the study authors. “The results of this analysis indicate how Twitter can be used to support early warning systems in outbreak surveillance efforts in settings where surveillance systems are not optimal.”
Content analysis of the tweets revealed that the main topics of concern in the tweets were Ebola risk factors, prevention education and health information, spread and location of Ebola, and compassion for countries in Africa.
Original publication
Michelle Odlum and Sunmoo Yoon; “What can we learn about the Ebola outbreak from tweets?”; American Journal of Infection Control, Volume 43, Issue 6 (June 2015).
Most read news
Original publication
Michelle Odlum and Sunmoo Yoon; “What can we learn about the Ebola outbreak from tweets?”; American Journal of Infection Control, Volume 43, Issue 6 (June 2015).
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.